MEDICINAL INHALATION AEROSOL FORMULATIONS CONTAINING BUDESONIDE

摘要

A PHARMACEUTICAL AEROSOL FORMULATION, SUITABLE FOR ADMINISTRATION BY ORAL OR NASAL INHALATION, CONTAINING A SUSPENSION OF PARTICULATE BUDESONIDE, HYDROFLUOROALKANE PROPELLANT AND, OPTIONALLY, ADDITIONAL HYDROFLUOROALKANE PROPELLANTS, SURFACTANT SELECTED FROM OLEIC ACID, SORBITAN OLEATES AND LECITHIN, AND ADJUVANT HAVE A KAURI-BUTANOL VALUE OF AT LEAST 10.